Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2.
View Top Employees from Coriolis PharmaWebsite | https://www.coriolis-pharma.com |
Revenue | $18.6 million |
Employees | 183 (155 on RocketReach) |
Founded | 2008 |
Phone | +49 89 4177600 |
Fax | +49 89 417760222 |
Technologies |
JavaScript,
HTML,
PHP
+24 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceutical, Manufacturing, Health Care |
Web Rank | 3 Million |
Keywords | Drug Development And Manufacturing |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Coriolis Pharma employee's phone or email?
The Coriolis Pharma annual revenue was $18.6 million in 2024.
Silvia Steyrer-Gruber is the CEO of Coriolis Pharma.
155 people are employed at Coriolis Pharma.
The NAICS codes for Coriolis Pharma are [32, 3254, 325, 32541].
The SIC codes for Coriolis Pharma are [28, 283].